We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Pfizer Expands Chantix Recall Due to Nitrosamine Contamination
Pfizer Expands Chantix Recall Due to Nitrosamine Contamination
Pfizer has broadened its recall of its smoking cessation drug Chantix (varenicline) to include all 0.5 and 1 mg products because of elevated levels of a nitrosamine contaminant.